Search

October 31, 2025 Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain receive the 2025 Merkin Prize at the Broad Institute for chimeric antigen receptor (CAR) T-cell therapy Produced by the Heritage Provider Network video team This groundbreaking form of personalized cancer immunotherapy...

FOR IMMEDIATE RELEASE CONTACT Karen Zusi-Tran Broad Institute kzusi@broadinstitute.org Janet Janjigian Heritage Provider Network janjigianj@carmengroup.com 424-354-0133 The winners are Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain, who developed technology that reprograms patients’...

This groundbreaking form of personalized cancer immunotherapy has had remarkable success — more than 45,000 cancer patients worldwide have been treated with CAR T-cell therapy, extending their lives and, in many cases, delivering complete and sustained remissions.

The groundbreaking, scalable technology is widely used in laboratories around the world today to efficiently produce large amounts of protein and RNA.

CONTACT Sarah Farris sarah@comsint.com VIDEO Link The $400,000 award recognizes the far-reaching medical impact of Dr. Caruthers’ development, in the early 1980s, of an efficient and fast method to synthesize nucleic acids. Cambridge, MA (June 28, 2023)—Dr. Marvin H. Caruthers of the University of...

F. William Studier was born in 1936 in Waverly, Iowa and went to Yale (BS, Biophysics, 1958), Caltech (PhD, Biophysics, 1963), and Stanford University for postdoctoral research in biochemistry. In 1964 he joined the biology department in Brookhaven National Laboratory, which he chaired from 1990...